ABEONA THERAPEUTICS INC (ABEO) — insider trading
Health Care · NASDAQ
ABEONA THERAPEUTICS INC (ABEO) has 27 reported SEC Form 4 insider transactions in our data, including 24 open-market sales among the most recent 27 (latest 2026-09-29).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Seshadri Vishwas | Director, Officer (Chief Executive Officer) | Open-market sale | 19,608 | $5.16 | $101.1K | Form 4 |
| 2026-09-29 | Vazzano Joseph Walter | Officer (Chief Financial Officer) | Open-market sale | 9,191 | $5.16 | $47.4K | Form 4 |
| 2026-09-29 | O'Malley Brendan M. | Officer (SVP, Chief Legal Officer) | Open-market sale | 6,727 | $5.16 | $34.7K | Form 4 |
| 2026-09-29 | Vasanthavada Madhav | Officer (Chief Commercial Officer) | Open-market sale | 4,902 | $5.16 | $25.3K | Form 4 |
| 2026-09-01 | Alvino Mark | Director | Open-market sale | 15,000 | $5.86 | $88.0K | Form 4 |
| 2026-07-21 | Vazzano Joseph Walter | Officer (Chief Financial Officer) | Open-market sale | 1,478 | $6.53 | $9.7K | Form 4 |
| 2026-07-09 | Vasanthavada Madhav | Officer (Chief Commercial Officer) | Open-market sale | 12,606 | $6.96 | $87.8K | Form 4 |
| 2026-07-09 | O'Malley Brendan M. | Officer (SVP, Chief Legal Officer) | Open-market sale | 12,050 | $6.96 | $83.9K | Form 4 |
| 2026-07-09 | Seshadri Vishwas | Director, Officer (Chief Executive Officer) | Open-market sale | 67,971 | $6.96 | $473.3K | Form 4 |
| 2026-07-09 | Vazzano Joseph Walter | Officer (Chief Financial Officer) | Open-market sale | 24,880 | $6.96 | $173.3K | Form 4 |
| 2026-06-30 | Alland Leila | Director | Open-market sale | 11,000 | $5.92 | $65.1K | Form 4 |
| 2026-06-16 | Vasanthavada Madhav | Officer (Chief Commercial Officer) | Other acquisition or disposition | 222 | $5.67 | $1.3K | Form 4 |
| 2026-06-15 | Silverstein Christine Berni | Director | Open-market sale | 18,160 | $5.71 | $103.7K | Form 4 |
| 2026-06-09 | Seshadri Vishwas | Director, Officer (Chief Executive Officer) | Open-market sale | 31,916 | $5.30 | $169.3K | Form 4 |
| 2026-06-09 | Vasanthavada Madhav | Officer (Chief Commercial Officer) | Open-market sale | 5,450 | $5.30 | $28.9K | Form 4 |
| 2026-06-09 | Vazzano Joseph Walter | Officer (Chief Financial Officer) | Open-market sale | 25,646 | $5.39 | $138.3K | Form 4 |
| 2026-06-09 | Vazzano Joseph Walter | Officer (Chief Financial Officer) | Open-market sale | 13,421 | $5.30 | $71.2K | Form 4 |
| 2026-06-09 | O'Malley Brendan M. | Officer (SVP, Chief Legal Officer) | Open-market sale | 6,305 | $5.30 | $33.4K | Form 4 |
| 2026-06-08 | Seshadri Vishwas | Director, Officer (Chief Executive Officer) | Open-market sale | 24,428 | $5.43 | $132.6K | Form 4 |
| 2026-06-08 | Vasanthavada Madhav | Officer (Chief Commercial Officer) | Open-market sale | 4,170 | $5.43 | $22.6K | Form 4 |
| 2026-06-08 | Vazzano Joseph Walter | Officer (Chief Financial Officer) | Open-market sale | 10,271 | $5.43 | $55.8K | Form 4 |
| 2026-06-08 | O'Malley Brendan M. | Officer (SVP, Chief Legal Officer) | Open-market sale | 4,826 | $5.43 | $26.2K | Form 4 |
| 2026-05-26 | Alvino Mark | Director | Bona fide gift | 500 | — | $0 | Form 4 |
| 2026-05-22 | Alvino Mark | Director | Open-market sale | 6,500 | $5.46 | $35.5K | Form 4 |
| 2026-05-15 | Crombez Eric | Director | Open-market sale | 26,143 | $5.53 | $144.6K | Form 4 |
| 2026-05-11 | Vasanthavada Madhav | Officer (Chief Commercial Officer) | Open-market sale | 5,548 | $5.96 | $33.1K | Form 4 |
| 2026-04-01 | Goldan Keith A. | Director | Grant / award / vesting | 32,751 | — | $0 | Form 4 |
Ask the chat about ABEO's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ABEONA THERAPEUTICS INC (ABEO).
Last updated 2026-09-29 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.